BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15250270)

  • 21. Extracorporeal blood purification in the management of patients with hepatic failure.
    Kaplan AA; Epstein M
    Semin Nephrol; 1997 Nov; 17(6):576-82. PubMed ID: 9353867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Adiponectin Levels in Acute Liver Failure Patients Treated with Plasma Filtration with Dialysis and Plasma Exchange.
    Yamamoto H; Nakae H; Uji Y; Maeda K; Tani T; Eguchi Y
    Ther Apher Dial; 2015 Aug; 19(4):349-54. PubMed ID: 26386223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost-effect analysis of blood plasma replacement for the treatment of liver failure].
    Liu YH; Peng D; Zhu S; Li Z; Lu Q; Wu XN
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):624-5. PubMed ID: 19719925
    [No Abstract]   [Full Text] [Related]  

  • 24. [The evaluation for principles and clinical application of combined artificial liver therapy].
    GUO LM
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):326-7. PubMed ID: 19497192
    [No Abstract]   [Full Text] [Related]  

  • 25. The Forgotten Issue of Glucose Delivery to Diabetes Patients in On-Line Hemodiafiltration.
    Marano M; Cirillo G
    Ther Apher Dial; 2016 Apr; 20(2):205. PubMed ID: 26916599
    [No Abstract]   [Full Text] [Related]  

  • 26. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes.
    Navarro J; Serrano C; Donna E; Perez GO
    ASAIO J; 1992; 38(4):811-4. PubMed ID: 1450477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment.
    Mao W; Ye B; Lin S; Fu Y; Chen Y; Chen Y
    ASAIO J; 2010; 56(5):475-8. PubMed ID: 20613491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Change of blood parameters in liver failure patients with severe hepatitis after combined therapy].
    Lin JH; Guo YX; Zhou XH; Chen FS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):103-5. PubMed ID: 12857471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 30. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
    Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
    Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous hemodiafiltration during aortic arch aneurysm repair in chronic renal failure patient.
    Sugawara Y; Sato O; Miyata T; Kimura H; Yasunaga H; Suzuki S; Makuuchi M
    Panminerva Med; 1998 Mar; 40(1):63-5. PubMed ID: 9573758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Online hemodiafiltration.
    Van Laecke S; De Wilde K; Vanholder R
    Artif Organs; 2006 Aug; 30(8):579-85. PubMed ID: 16911311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood purification in chronic renal failure with severe liver disease].
    Sudo M
    Nihon Rinsho; 1992 Jan; 50 Suppl():112-7. PubMed ID: 1578663
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltration for bridging severe acute liver failure.
    Biancofiore G; Bindi LM; Urbani L; Catalano G; Mazzoni A; Scatena F; Mosca F; Filipponi F
    Transplant Proc; 2003 Dec; 35(8):3011-4. PubMed ID: 14697964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa; Kirkhman VV; Timokhov VS
    Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical use of a new hydrate cellulose membrane for hemodialysis].
    Baeva LB; Levitskiĭ ER; Poddubnaia LP; Makhortov NS; Zaĭtsev VG
    Ter Arkh; 1983; 55(6):98-100. PubMed ID: 6612628
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immediate effect of hemodialysis with cuprophane membrane and acetate containing dialysis fluid on respiratory function in patients with chronic renal failure].
    Wanic-Kossowska M
    Pol Tyg Lek; 1993 Feb 15-22; 48(7-8):175-7. PubMed ID: 8415262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of severe hepatitis treated with a hybrid artificial liver support system].
    Li LJ; Yang Q; Huang JR; Li J; Cao HC; Chen YM; Chen YG; Cheng JF; Fu SZ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):458-60. PubMed ID: 12939173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure.
    Pichaiwong W; Leelahavanichkul A; Eiam-ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S65-72. PubMed ID: 17044456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
    Kuhlmann MK
    Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.